CTI BIOPHARMA CORP Quarterly Unrecognized Tax Benefits in USD from Q4 2014 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Cti Biopharma Corp quarterly Unrecognized Tax Benefits history and growth rate from Q4 2014 to Q4 2022.
  • Cti Biopharma Corp Unrecognized Tax Benefits for the quarter ending December 31, 2022 was $2.82M, a 133% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $2.82M +$1.61M +133% Dec 31, 2022 10-K 2023-03-06
Q4 2021 $1.21M +$819K +210% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $390K -$878K -69.2% Dec 31, 2020 10-K 2023-03-06
Q4 2019 $1.27M +$1.27M Dec 31, 2019 10-K 2022-03-31
Q4 2018 $0 $0 Dec 31, 2018 10-K 2021-03-17
Q4 2017 $0 $0 Dec 31, 2017 10-K 2020-03-13
Q4 2016 $0 $0 Dec 31, 2016 10-K 2017-03-02
Q4 2015 $0 $0 Dec 31, 2015 10-K 2016-02-17
Q4 2014 $0 Dec 31, 2014 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.